Market Cap 1.84B
Revenue (ttm) 445.76M
Net Income (ttm) 24.14M
EPS (ttm) N/A
PE Ratio 26.34
Forward PE 29.68
Profit Margin 5.42%
Debt to Equity Ratio 0.00
Volume 1,741,700
Avg Vol 1,420,528
Day's Range N/A - N/A
Shares Out 78.32M
Stochastic %K 23%
Beta 2.07
Analysts Strong Sell
Price Target $40.33

Company Profile

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 650 243 6300
Fax: 650 243 6388
Address:
6000 Shoreline Court, Suite 300, South San Francisco, United States
Enterprisal
Enterprisal Jul. 29 at 11:06 PM
$VCYT so Cathie Wood snapped up 262,000 shares.
0 · Reply
spongebob_squaretrades
spongebob_squaretrades Jul. 29 at 1:20 PM
$VCYT Counting after-hours, volume on 7/28 was 11.6x 10-day average, and traded within a 3% range all day, settling on the close down -0.91%. Insane! It effectively went almost nowhere on insane volume. Lots of trading interest, lots of uncertainty. Either a huge amount of churn or 1+ large sellers and 1+ large buyers duking it out. Something is up. Perhaps a stalemate in sentiment amongst some large players. Either that or massive day trading, though it seems like an odd stock to attract that portion of the market, IMHO. Perhaps related to the Smallcap 600 index addition. I'm stumped, but regardless of short-term noise, this company is under-valued. Another performer getting their house in order to prep it for future growth (similar to PSNL, though not as far along that process internally).
0 · Reply
ChillllinTheMost
ChillllinTheMost Jul. 28 at 1:21 PM
$VCYT am I the only one that seems like a $DGX $LH or $TEM could come in and buy this cash rich company?
0 · Reply
PhishTourFunds
PhishTourFunds Jul. 26 at 1:39 AM
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 25 at 11:33 AM
$VCYT (+6.4% pre) Veracyte Secures Major Index Upgrade: Latest Healthcare Addition to S&P SmallCap 600 https://ooc.bz/l/71203
0 · Reply
G101SPM
G101SPM Jul. 25 at 10:24 AM
$VCYT $25.14 ask. BUY/3X AD TO LONG POSITION carries SPM 87.21 tag to $35.00 (adjusted EXIT) misterm. DAC (dollar average cost includes this BUY). (4) $28.84.
1 · Reply
PhishTourFunds
PhishTourFunds Jul. 25 at 12:07 AM
$VCYT Almost 300k shares at $23.59 first ten minutes of after hours - looks like one order. Then a 10% phatty candle 💪
0 · Reply
XkaliburTrading
XkaliburTrading Jul. 24 at 10:48 PM
$VCYT https://www.benzinga.com/pressreleases/25/07/n46619600/veracyte-set-to-join-s-p-smallcap-600
0 · Reply
PhishTourFunds
PhishTourFunds Jul. 24 at 1:18 AM
$VCYT …out here talking to nobody #BullishClose
0 · Reply
PhishTourFunds
PhishTourFunds Jul. 22 at 2:47 AM
$VCYT 1 year chart - the phat candle on the left hand side includes a dip below $20 This channel is live!
0 · Reply
Latest News on VCYT
Veracyte to Participate in Upcoming Investor Conferences

May 20, 2025, 5:00 PM EDT - 2 months ago

Veracyte to Participate in Upcoming Investor Conferences


Veracyte, Inc. (VCYT) Q1 2025 Earnings Call Transcript

May 8, 2025, 12:49 AM EDT - 3 months ago

Veracyte, Inc. (VCYT) Q1 2025 Earnings Call Transcript


Veracyte Announces First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 3 months ago

Veracyte Announces First Quarter 2025 Financial Results


Solid Growth, Soft Outlook: Why I'm Holding On Veracyte

Feb 25, 2025, 10:32 AM EST - 5 months ago

Solid Growth, Soft Outlook: Why I'm Holding On Veracyte


Veracyte, Inc. (VCYT) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 10:53 PM EST - 5 months ago

Veracyte, Inc. (VCYT) Q4 2024 Earnings Call Transcript


Veracyte, Inc. (VCYT) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 10:49 PM EST - 9 months ago

Veracyte, Inc. (VCYT) Q3 2024 Earnings Call Transcript


Veracyte Announces Third Quarter 2024 Financial Results

Nov 6, 2024, 4:05 PM EST - 9 months ago

Veracyte Announces Third Quarter 2024 Financial Results


Veracyte, Inc. (VCYT) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 10:17 PM EDT - 1 year ago

Veracyte, Inc. (VCYT) Q2 2024 Earnings Call Transcript


Veracyte Announces Second Quarter 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Veracyte Announces Second Quarter 2024 Financial Results


Veracyte Announces First Quarter 2024 Financial Results

May 7, 2024, 4:05 PM EDT - 1 year ago

Veracyte Announces First Quarter 2024 Financial Results


Veracyte, Inc. (VCYT) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 9:24 PM EST - 1 year ago

Veracyte, Inc. (VCYT) Q4 2023 Earnings Call Transcript


Veracyte Completes Acquisition of C2i Genomics

Feb 6, 2024, 8:15 AM EST - 1 year ago

Veracyte Completes Acquisition of C2i Genomics


Veracyte, Inc. (VCYT) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 8:57 PM EST - 1 year ago

Veracyte, Inc. (VCYT) Q3 2023 Earnings Call Transcript


Enterprisal
Enterprisal Jul. 29 at 11:06 PM
$VCYT so Cathie Wood snapped up 262,000 shares.
0 · Reply
spongebob_squaretrades
spongebob_squaretrades Jul. 29 at 1:20 PM
$VCYT Counting after-hours, volume on 7/28 was 11.6x 10-day average, and traded within a 3% range all day, settling on the close down -0.91%. Insane! It effectively went almost nowhere on insane volume. Lots of trading interest, lots of uncertainty. Either a huge amount of churn or 1+ large sellers and 1+ large buyers duking it out. Something is up. Perhaps a stalemate in sentiment amongst some large players. Either that or massive day trading, though it seems like an odd stock to attract that portion of the market, IMHO. Perhaps related to the Smallcap 600 index addition. I'm stumped, but regardless of short-term noise, this company is under-valued. Another performer getting their house in order to prep it for future growth (similar to PSNL, though not as far along that process internally).
0 · Reply
ChillllinTheMost
ChillllinTheMost Jul. 28 at 1:21 PM
$VCYT am I the only one that seems like a $DGX $LH or $TEM could come in and buy this cash rich company?
0 · Reply
PhishTourFunds
PhishTourFunds Jul. 26 at 1:39 AM
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 25 at 11:33 AM
$VCYT (+6.4% pre) Veracyte Secures Major Index Upgrade: Latest Healthcare Addition to S&P SmallCap 600 https://ooc.bz/l/71203
0 · Reply
G101SPM
G101SPM Jul. 25 at 10:24 AM
$VCYT $25.14 ask. BUY/3X AD TO LONG POSITION carries SPM 87.21 tag to $35.00 (adjusted EXIT) misterm. DAC (dollar average cost includes this BUY). (4) $28.84.
1 · Reply
PhishTourFunds
PhishTourFunds Jul. 25 at 12:07 AM
$VCYT Almost 300k shares at $23.59 first ten minutes of after hours - looks like one order. Then a 10% phatty candle 💪
0 · Reply
XkaliburTrading
XkaliburTrading Jul. 24 at 10:48 PM
$VCYT https://www.benzinga.com/pressreleases/25/07/n46619600/veracyte-set-to-join-s-p-smallcap-600
0 · Reply
PhishTourFunds
PhishTourFunds Jul. 24 at 1:18 AM
$VCYT …out here talking to nobody #BullishClose
0 · Reply
PhishTourFunds
PhishTourFunds Jul. 22 at 2:47 AM
$VCYT 1 year chart - the phat candle on the left hand side includes a dip below $20 This channel is live!
0 · Reply
PhishTourFunds
PhishTourFunds Jul. 21 at 5:08 PM
$VCYT Scale in!
1 · Reply
PhishTourFunds
PhishTourFunds Jul. 19 at 3:37 AM
$VCYT oversold, RSI reset, 200MA is $35
1 · Reply
macroaxis
macroaxis Jul. 19 at 12:07 AM
$VCYT – Rising Volatility: Increased Pin Risk in Veracyte Options—Investors Caution Advised https://www.macroaxis.com/stock-options/VCYT/Veracyte?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
ZacksResearch
ZacksResearch Jul. 16 at 1:03 PM
$VCYT: Solid fundamentals but facing headwinds — what's next? 🤔 ✅ Strong growth drivers: NIGHTINGALE study & Decipher franchise's 37% test volume growth 📉 Yet, biopharma declines & macro challenges, including rising expenses, loom large Opportunity assessment here 👉 https://www.zacks.com/stock/news/2585054/should-you-continue-to-hold-veracyte-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2585054-body-1985&ADID=SYND_STOCKTWITS_TWEET_2_2585054_BODY_1985
0 · Reply
ZacksResearch
ZacksResearch Jul. 16 at 11:39 AM
$VCYT showing strength with Decipher momentum and solid cash — but is that enough? Biopharma headwinds and macro risks still threaten the bull case, raising legit questions for holders. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2585054/should-you-continue-to-hold-veracyte-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2585054-teaser-1945&ADID=SYND_STOCKTWITS_TWEET_2_2585054_TEASER_1945
0 · Reply
G101SPM
G101SPM Jul. 11 at 6:45 PM
#SHOWTIME ^ H.C. Wainwright Kidney Virtual Conference (July 14) Scheduled to appear: $AKBA, $UNCY ^ Endocrine Society Meeting (July 14-15) Scheduled to appear: $CRNX, $VCYT
1 · Reply
thecontracap
thecontracap Jul. 1 at 10:33 PM
$MDXH $XGN $VCYT $CDNA $MYGN $MDXH is the best combo of growth and value in diagnostics. 1.3x sales, 20% growth for 16 straight quarters with long runway ahead. Turning profitable this qtr, as they leverage costs and grow without adding sales reps. I expect 20%+ growth going forward- $15MM+ EBITDA in 26 and $30MM+ in 27, making this trade at <5x 27 ebitda while growing rev 20%+. Stock at $2.12, my 18 month price target is $8. I wrote it up- if interested, dm me and I will send.
1 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jun. 18 at 9:14 PM
Veracyte ($VCYT) shareholders approved a 2.5M share increase for employee incentives today. While dilution concerns showed in the 50.6M For vs 19.1M Against vote, this fuels talent retention for their precision oncology push. At 64x earnings, every equity move matters. Execution pressure mounts with $186M cash reserves. https://www.sec.gov/Archives/edgar/data/1384101/000138410125000083/vcyt-20250617.htm
0 · Reply
SilverEagle
SilverEagle Jun. 13 at 3:55 PM
$VCYT add it to your WL.
0 · Reply
Bgirl_smirk
Bgirl_smirk Jun. 10 at 4:44 AM
$VCYT looks like finally a buy
1 · Reply
OpenOutcrier
OpenOutcrier May. 29 at 12:00 PM
$VCYT (+3.9% pre) Veracyte, Inc. (VCYT) Presents Breakthrough Genomic Data to Predict Cancer Therapy Response at ASCO https://ooc.bz/l/66190
0 · Reply
Armonica423
Armonica423 May. 10 at 9:53 PM
$VCYT Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research
0 · Reply